VISKOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Viskase Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$4.05−0.09 (-2.27%)
Close on Oct 19, 2026
- Market cap
- $58.04M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q4 FY2012 Ended Dec 31, 2012 | Mar 18, 2013 | During market hours | – | – | – |
| Q3 FY2012 Ended Sep 30, 2012 | Oct 31, 2012 | Before market open | – | – | – |
| Q2 FY2012 Ended Jun 30, 2012 | Aug 1, 2012 | Before market open | – | – | – |
| Q1 FY2012 Ended Mar 31, 2012 | May 2, 2012 | Before market open | – | – | – |
| Q4 FY2011 Ended Dec 31, 2011 | Mar 12, 2012 | Before market open | – | – | – |
| Q3 FY2011 Ended Sep 30, 2011 | Nov 3, 2011 | During market hours | – | – | – |
| Q2 FY2011 Ended Jun 30, 2011 | Aug 4, 2011 | Before market open | – | – | – |
| Q1 FY2011 Ended Mar 31, 2011 | May 6, 2011 | Before market open | – | – | – |
| Q4 FY2010 Ended Dec 31, 2010 | Feb 17, 2011 | During market hours | – | – | – |
| Q3 FY2010 Ended Sep 30, 2010 | Nov 2, 2010 | During market hours | – | – | – |
| Q2 FY2010 Ended Jun 30, 2010 | Aug 3, 2010 | During market hours | – | – | – |
| Q1 FY2010 Ended Mar 31, 2010 | May 10, 2010 | Before market open | – | – | – |
Press releases
Announcements Viskase filed with the SEC
Viskase Holdings, Inc. Adopts Tax Benefits
Material agreement · Charter or bylaw amendment · Regulation FD disclosure · EX-99.1 to Form 8-K
Enzon Pharmaceuticals Completes Merger with
Acquisition or disposition completed · Unregistered share sale · Executive or director change · Charter or bylaw amendment · Regulation FD disclosure · EX-99.1 to Form 8-K
Enzon Announces Reverse Stock Split
Material agreement · Charter or bylaw amendment · Regulation FD disclosure · EX-99.1 to Form 8-K
Enzon and Viskase Announce Amendment to Merger
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
Enzon and Viskase Enter into Merger Agreement
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
Review of Possible Asset Sales, Sale of the Company;
Other events · EX-99.1 to Form 8-K
PISCATAWAY, N.J. – November 29, 2012
Other events · EX-99.1 to Form 8-K
PISCATAWAY, N.J. – October 31,
Results of operations · EX-99.1 to Form 8-K